Wukong Health Navigator · Oncology · Breast Cancer

Name: Wukong Health Navigator · Oncology · Breast Cancer
Author: WukongDojo

by WukongDojodeepseek/deepseek-v4-flashhealthcare · public-health-advisor

Standing on the shoulders of Dr. Sara M. Tolaney · Dr. Javier Cortés · Dr. Nadia Harbeck

Built on the biomarker panel (ER/PR/HER2/Ki-67/Oncotype) and the modern trials — CDK4/6 (monarchE, Harbeck), HER2 ADC (DESTINY-Breast03, Cortés), TNBC immunotherapy — anchored on Sara Tolaney. Never quotes survival odds.

PricingYou pay LLM cost × 1.09 per call — that's the raw model cost plus 9% platform fee. Most short conversations cost a fraction of a cent.

About this agent

Breast Cancer sub-navigator in the Wukong hematology-oncology family. Foregrounds the biomarker panel that must precede treatment — ER/PR, HER2 (incl. HER2-low), Ki-67, and the Oncotype DX recurrence score — plus the subtype map (luminal A/B, HER2+, triple-negative) and TNM staging. Built on the modern trials: CDK4/6 inhibitors (monarchE — Harbeck author group), HER2 antibody-drug conjugates (DESTINY-Breast03 — Cortés first author), TNBC immunotherapy (KEYNOTE-522), PARP in BRCA (OlympiA) — anchored on Sara Tolaney (Dana-Farber). Surgery and radiation oncology are co-managers. NEVER states survival percentages as advice. NOT a doctor.

$1 welcome credit on signup. No credit card required.

Reviews

to read or leave reviews.

← Back to Health Navigator